Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 12 | $51,057,237 |
Sells | 269 | $223,779,289 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Jan 2024 19:49 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 26 Jan 2024 | Sale | 100 | 25 | 2,500 | D |
13 Dec 2022 17:06 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 12 Dec 2022 | Sale | 312 | 10.87 | 3,391 | D |
26 Jan 2024 19:48 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 26 Jan 2024 | Sale | 178 | 25.14 | 4,475 | D |
13 Dec 2022 17:05 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 12 Dec 2022 | Sale | 472 | 10.87 | 5,131 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 210 | 25.25 | 5,302 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 210 | 25.25 | 5,302 | I |
13 Dec 2022 17:04 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Dec 2022 | Sale | 628 | 10.87 | 6,826 | D |
13 Dec 2022 17:03 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 12 Dec 2022 | Sale | 680 | 10.87 | 7,392 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 08 Mar 2024 | Sale | 289 | 27.33 | 7,898 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 08 Mar 2024 | Sale | 291 | 27.41 | 7,976 | D |
13 Dec 2022 17:05 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 12 Dec 2022 | Sale | 751 | 10.87 | 8,163 | D |
06 Dec 2023 18:13 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 04 Dec 2023 | Sale | 681 | 12.01 | 8,179 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 360 | 25.25 | 9,090 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 360 | 25.25 | 9,090 | I |
28 Feb 2024 17:06 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 28 Feb 2024 | Sale | 407 | 25 | 10,175 | D |
12 Dec 2023 17:33 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Dec 2023 | Sale | 978 | 10.55 | 10,318 | D |
20 Sep 2023 16:49 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 18 Sep 2023 | Sale | 1,261 | 9.41 | 11,866 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 08 Mar 2024 | Sale | 435 | 27.38 | 11,910 | D |
20 Aug 2024 16:27 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 19 Aug 2024 | Sale | 261 | 46 | 12,006 | D |
20 Sep 2023 16:49 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 18 Sep 2023 | Sale | 1,290 | 9.41 | 12,139 | D |
17 May 2024 21:06 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 16 May 2024 | Sale | 425 | 28.59 | 12,151 | D |
15 Mar 2023 17:50 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 13 Mar 2023 | Sale | 1,000 | 13 | 13,000 | D |
14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 12 Jun 2023 | Sale | 1,000 | 13 | 13,000 | D |
13 Sep 2023 19:53 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 12 Sep 2023 | Sale | 1,266 | 10.41 | 13,179 | D |
17 May 2024 21:04 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 16 May 2024 | Sale | 462 | 28.59 | 13,209 | D |
12 Dec 2023 17:34 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Dec 2023 | Sale | 1,245 | 10.72 | 13,346 | D |
20 Sep 2023 16:47 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 18 Sep 2023 | Sale | 1,436 | 9.41 | 13,513 | D |
20 Aug 2024 16:26 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 19 Aug 2024 | Sale | 296 | 46 | 13,616 | D |
17 May 2024 21:07 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 16 May 2024 | Sale | 483 | 28.59 | 13,809 | D |
17 May 2024 21:05 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 16 May 2024 | Sale | 489 | 28.59 | 13,981 | D |
20 Aug 2024 16:27 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 19 Aug 2024 | Sale | 305 | 46 | 14,030 | D |
17 May 2024 21:03 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 16 May 2024 | Sale | 495 | 28.59 | 14,152 | D |
20 Aug 2024 16:28 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 19 Aug 2024 | Sale | 310 | 46 | 14,260 | D |
13 Sep 2023 19:53 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 12 Sep 2023 | Sale | 1,397 | 10.41 | 14,543 | D |
12 Dec 2023 17:35 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 11 Dec 2023 | Sale | 1,380 | 10.72 | 14,794 | D |
20 Aug 2024 16:26 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 19 Aug 2024 | Sale | 328 | 46 | 15,088 | D |
13 Sep 2023 19:50 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 12 Sep 2023 | Sale | 1,484 | 10.41 | 15,448 | D |
14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 13 Jun 2023 | Sale | 1,259 | 12.43 | 15,649 | D |
12 Dec 2023 17:32 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Dec 2023 | Sale | 1,467 | 10.72 | 15,726 | D |
15 Mar 2023 17:50 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 14 Mar 2023 | Sale | 1,209 | 13.33 | 16,116 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 01 Mar 2024 | Sale | 564 | 28.65 | 16,159 | D |
13 Sep 2023 19:51 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 12 Sep 2023 | Sale | 1,635 | 10.41 | 17,020 | D |
15 Jun 2023 17:46 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 13 Jun 2023 | Sale | 1,390 | 12.43 | 17,278 | D |
12 Dec 2023 17:34 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 11 Dec 2023 | Sale | 1,616 | 10.72 | 17,324 | D |
15 Mar 2023 17:51 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 14 Mar 2023 | Sale | 1,311 | 13.33 | 17,476 | D |
13 Sep 2023 19:56 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Sep 2023 | Sale | 1,707 | 10.41 | 17,770 | D |
12 Dec 2023 17:33 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Dec 2023 | Sale | 1,688 | 10.72 | 18,095 | D |
14 Jun 2023 18:39 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 13 Jun 2023 | Sale | 1,475 | 12.43 | 18,334 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 689 | 27.31 | 18,817 | D |
15 Mar 2023 17:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 14 Mar 2023 | Sale | 1,416 | 13.33 | 18,875 | D |
26 Aug 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 22 Aug 2024 | Sale | 413 | 46.97 | 19,399 | I |
14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 13 Jun 2023 | Sale | 1,625 | 12.43 | 20,199 | D |
15 Mar 2023 17:50 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 14 Mar 2023 | Sale | 1,559 | 13.33 | 20,781 | D |
14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 13 Jun 2023 | Sale | 1,698 | 12.43 | 21,106 | D |
06 Dec 2023 18:13 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 06 Dec 2023 | Sale | 1,872 | 12.01 | 22,483 | D |
20 Sep 2023 16:48 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 18 Sep 2023 | Sale | 2,672 | 9.41 | 25,144 | D |
04 Sep 2024 17:42 | DYN | Dyne Therapeutics Inc | COX JOHN | CEO & President | 04 Sep 2024 | Purchase | 800 | 32.57 | 26,056 | I |
04 Sep 2024 17:42 | DYN | Dyne Therapeutics Inc | COX JOHN | CEO & President | 04 Sep 2024 | Purchase | 800 | 32.57 | 26,056 | I |
04 Sep 2024 17:42 | DYN | Dyne Therapeutics Inc | COX JOHN | CEO & President | 04 Sep 2024 | Purchase | 800 | 32.57 | 26,056 | I |
04 Sep 2024 17:42 | DYN | Dyne Therapeutics Inc | COX JOHN | CEO & President | 04 Sep 2024 | Purchase | 800 | 32.57 | 26,056 | I |
12 Mar 2024 21:58 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Mar 2024 | Sale | 1,030 | 25.58 | 26,347 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 11 Mar 2024 | Sale | 1,082 | 25.7 | 27,807 | D |
14 Dec 2023 16:59 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 14 Dec 2023 | Sale | 2,376 | 12.02 | 28,560 | D |
11 Jun 2024 19:41 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Jun 2024 | Sale | 1,008 | 31.27 | 31,520 | D |
13 Dec 2022 17:04 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 12 Dec 2022 | Sale | 3,322 | 10.87 | 36,110 | D |
04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 04 Jan 2024 | Sale | 2,009 | 18.04 | 36,242 | D |
22 May 2024 21:01 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 20 May 2024 | Sale | 1,145 | 34.08 | 39,022 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 11 Mar 2024 | Sale | 1,590 | 24.99 | 39,734 | D |
12 Mar 2024 21:58 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Mar 2024 | Sale | 1,585 | 25.7 | 40,734 | D |
11 Mar 2024 21:52 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 07 Mar 2024 | Sale | 1,557 | 26.2 | 40,793 | D |
11 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 07 Mar 2024 | Sale | 1,591 | 25.85 | 41,127 | D |
11 Jun 2024 19:28 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 11 Jun 2024 | Sale | 1,331 | 31.34 | 41,714 | D |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 01 Mar 2024 | Sale | 1,414 | 29.7 | 41,996 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 1,442 | 29.7 | 42,827 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Mar 2024 | Sale | 1,776 | 25.71 | 45,661 | D |
18 Sep 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 16 Sep 2024 | Sale | 1,320 | 35.04 | 46,253 | I |
11 Sep 2024 16:13 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 11 Sep 2024 | Sale | 1,468 | 31.89 | 46,815 | D |
19 Sep 2024 16:52 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 18 Sep 2024 | Sale | 1,390 | 34.55 | 48,024 | D |
11 Jun 2024 19:28 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 10 Jun 2024 | Sale | 1,590 | 30.23 | 48,066 | D |
11 Jun 2024 19:41 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Jun 2024 | Sale | 1,628 | 31.27 | 50,908 | D |
14 Aug 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 09 Aug 2024 | Sale A | 1,160 | 44.04 | 51,086 | I |
12 Aug 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 09 Aug 2024 | Sale | 1,160 | 44.04 | 51,086 | I |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 15 Feb 2024 | Sale | 2,113 | 24.45 | 51,663 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 15 Feb 2024 | Sale | 2,113 | 24.45 | 51,663 | I |
12 Mar 2024 21:42 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Mar 2024 | Sale | 2,081 | 25.7 | 53,482 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 2,216 | 24.68 | 54,691 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 2,216 | 24.68 | 54,691 | I |
17 May 2024 21:06 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 16 May 2024 | Sale | 1,956 | 28.2 | 55,159 | D |
09 Sep 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 05 Sep 2024 | Sale | 1,577 | 35.03 | 55,242 | I |
10 Sep 2024 16:05 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 06 Sep 2024 | Sale | 1,700 | 32.63 | 55,471 | D |
11 Jun 2024 19:34 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Jun 2024 | Sale | 1,823 | 31.34 | 57,133 | D |
11 Mar 2024 21:45 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 07 Mar 2024 | Sale | 2,273 | 25.85 | 58,757 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 11 Mar 2024 | Sale | 2,292 | 25.7 | 58,904 | D |
17 May 2024 21:04 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 16 May 2024 | Sale | 2,126 | 28.2 | 59,953 | D |
11 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 07 Mar 2024 | Sale | 2,373 | 25.85 | 61,342 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 2,430 | 25.25 | 61,358 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 2,430 | 25.25 | 61,358 | D |
17 May 2024 21:07 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 16 May 2024 | Sale | 2,222 | 28.2 | 62,660 | D |
11 Mar 2024 21:50 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 07 Mar 2024 | Sale | 2,434 | 25.85 | 62,919 | D |
17 May 2024 21:05 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 16 May 2024 | Sale | 2,249 | 28.2 | 63,422 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)